Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.

Synthetic polymer vascular patches used in cardiovascular surgery have shortcomings such as thrombosis, intimal hyperplasia, calcification, infection, and no growth potential. Tissue-engineered vascular patches using autologous vascular cells may solve these problems. In this study, we developed a tissue-engineered vascular patch using autologous bone marrow-derived cells (BMCs) and decellularized tissue matrices. Vascular smooth muscle cells and endothelial cells were differentiated from bone marrow mononuclear cells in vitro. Tissue-engineered vascular patches were fabricated by seeding these cells onto decellularized canine inferior vena cava matrices and implanted into the inferior vena cava of dogs. Three weeks after implantation, the tissue-engineered vascular patches were patent with no sign of thrombus formation. Histological, immunohistochemical, and electron microscopic analyses of the vascular patches retrieved 3 weeks after implantation revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. BMCs labeled with a fluorescent dye prior to implantation were detected in the retrieved vascular patches, indicating that the BMCs survived after implantation and contributed to the vascular tissue regeneration. This study demonstrates that vascular patches can be tissue-engineered with autologous BMCs and decellularized tissue matrices.

[1]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[2]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[3]  J. Michel,et al.  Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. , 1994, Journal of vascular surgery.

[4]  Narutoshi Hibino,et al.  Successful application of tissue engineered vascular autografts: clinical experience. , 2003, Biomaterials.

[5]  M. Spector,et al.  Lapine and canine bone marrow stromal cells contain smooth muscle actin and contract a collagen-glycosaminoglycan matrix. , 2001, Tissue engineering.

[6]  M Komeda,et al.  A new acellular vascular prosthesis as a scaffold for host tissue regeneration. , 2003, The International journal of artificial organs.

[7]  J. Michel,et al.  Extracellular matrix remodeling in the vascular wall. , 2001, Pathologie-biologie.

[8]  A Haverich,et al.  Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.

[9]  Evan S. Garfein,et al.  First Evidence that Bone Marrow Cells Contribute to the Construction of Tissue Engineered Vascular Autografts In Vivo , 2004 .

[10]  P. Hagen,et al.  Remodeling of an acellular collagen graft into a physiologically responsive neovessel , 1999, Nature Biotechnology.

[11]  H. Daida,et al.  Isolation of Bone Marrow Stromal Cell-Derived Smooth Muscle Cells by a Human SM22alpha Promoter , 2003 .

[12]  H. Yeger,et al.  Acellular matrix allograft small caliber vascular prostheses. , 1990, ASAIO transactions.

[13]  J. Michel,et al.  The immunogenicity of the extracellular matrix in arterial xenografts. , 1997, Surgery.

[14]  J. Ricco,et al.  The Role of Polyester Patch Angioplasty in Carotid Endarterectomy: A Multicenter Study , 2000, Annals of vascular surgery.

[15]  B. Conklin,et al.  Development and evaluation of a novel decellularized vascular xenograft. , 2002, Medical engineering & physics.

[16]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[17]  C. Schmidt,et al.  Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. , 2000, Biomaterials.

[18]  A. Haverich,et al.  Cell seeded decellularised allogeneic matrix grafts and biodegradable polydioxanone-prostheses compared with arterial autografts in a porcine model. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  J. McEwan,et al.  Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.

[20]  P. Libby,et al.  Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.

[21]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[22]  H. Daida,et al.  Isolation of Bone Marrow Stromal Cell–Derived Smooth Muscle Cells by a Human SM22&agr; Promoter: In Vitro Differentiation of Putative Smooth Muscle Progenitor Cells of Bone Marrow , 2003, Circulation.

[23]  R. S. Hannay,et al.  Prospective randomized study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. , 2002, Journal of vascular surgery.

[24]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[25]  M A Moses,et al.  Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. , 2000, The Journal of thoracic and cardiovascular surgery.

[26]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[27]  V. J. Rhodes.  Expanded polytetrafluoroethylene patch angioplasty in carotid endarterectomy. , 1995, Journal of vascular surgery.

[28]  H. Suh,et al.  Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation. , 2001, Journal of biomedical materials research.

[29]  A Haverich,et al.  Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. , 2000, Transplantation.

[30]  R. Lord,et al.  A comparative thrombogenicity study of heparin soaked fluoro-passivated polyester and ePTFE patches in sheep. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  L. Lambert,et al.  Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. , 2003, The Journal of thoracic and cardiovascular surgery.

[32]  V. Koteliansky,et al.  Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. , 1993, Blood.